Galectin Therapeutics logo

Galectin Therapeutics

GALT | NASDAQ
Chart Builder DCF Calculator
$3.02
-$0.03 (-0.98%)
At close: Nov 16, 2026, 4:00 PM ET
$3.02
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.98%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
31
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #763/1021 (Top 75%)

Key Statistics

Market Data

Market Cap $198.89M
1D Range
2.93 3.22
52W Range
2.08 6.51

Valuation (TTM)

PE -7.02
PB -1.45
EV/EBITDA -23.51

Valuation (NTM)

Forward PE N/A
Forward PEG 0.18
Price Target $11.00
Loading financial charts...

Profile

Galectin Therapeutics Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing new therapies for a spectrum of illnesses, including fibrotic disord...

Sector Healthcare
Industry Biotechnology
Employees 9
IPO Date Sep 4, 2002
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$11.00
Upside
+264.24%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.